Takeda Pharmaceutical Co Ltd 2.05 percent 31Mar2030 is a Corporate bonds world rest issued by Takeda Pharmaceutical Co. Ltd. on the 29th of June 2020. The bond matures on the 31st of March 2030 and carries the semi-annual coupon of 2.050%. TAKEDA is trading at 84.18 as of the 21st of November 2024, a 2.39 percent decrease since the beginning of the trading day. The bond's open price was 86.24. TAKEDA has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for TAKEDA PHARMACEUTICAL LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Our tools can tell you how much better you can do entering a position in TAKEDA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Equity Forecasting Now
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
TAKEDA financial ratios help investors to determine whether TAKEDA Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TAKEDA with respect to the benefits of owning TAKEDA security.